�鶹ֱ��

KASBP Boston 2025-26 Dinner & Learn Series

�鶹ֱ�� & Lardner attorneys will be featured as presenters during the Korean American Society in Biotech and Pharmaceuticals (KASBP) Boston 2025-26 Dinner & Learn Series event titled “IP & FDA Regulatory Strategy in the AI Era.” Our speakers will first cover intellectual property (IP) and patent strategy for the unique challenges posed by protecting inventions stemming from the use of AI models in biotech and pharmaceuticals, including the use of clinical data and patent subject matter eligibility, and aligning patent filings with the regulatory approval process.  Second, we will delve into IP transactions and Food & Drug Administration (FDA) regulatory considerations when it comes to AI and pharmaceutical innovations.

Jolene Fernandes, Ph.D., and Austin Kim – “IP Strategy in the AI Era”

Kyle Faget and Brian Tomkins – “IP Transactions and Food & Drug Administration (FDA) Regulatory Considerations in the AI Era”

Agenda

• 5:00 – 6:00 PM Check-in and Dinner
• 6:00 – 7:00 PM Seminars
  • IP Strategy in the AI Era
    • Austin Kim, Senior Counsel, Patent Attorney
    • Jolene Fernandes, PhD, Partner, Patent Attorney
• 7:00 – 8:00 PM Panel Discussion
  • IP transactions and Food & Drug Administration (FDA) Regulatory Considerations in the AI Era
    • Kyle Faget, Partner, Co-Chair of Health Care & Life Sciences Sector
    • Brian Tomkins, Partner, Patent Attorney
• 8:00 – 9:00 PM Networking

Please click on this to register your attendance.

We look forward to connecting with you at this event.